Clinical Trial Update: Organoid-guided vs Topotecan Therapy in Relapsed Extensive-Stage Small Cell Lung Cancer [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial update comparing organoid-guided therapy to Topotecan for relapsed extensive-stage small cell lung cancer, with the study currently n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• Organoid-guided therapy
• Topotecan (topotecan)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Extensive-stage Small Cell Lung Cancer (ES-SCLC), Extensive-stage Small Cell Lung Cancer (SCLC) | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING